Shingles vaccination eligibility updated for 2015

The immunisation programme, now in its third year, aims to offer a single dose of shingles (herpes zoster) vaccine to all 70-79 year-olds.

By the end of April 2015, over half of all 70, 78 and 79 year olds had been vaccinated against shingles.
By the end of April 2015, over half of all 70, 78 and 79 year olds had been vaccinated against shingles.

NHS England and Public Health England have issued an update on the shingles immunisation programme.

From 1st September 2015, shingles vaccine (Zostavax) should be offered to:

  • Patients aged 70 years on 1st September 2015; and
  • Patients aged 78 years on 1st September 2015.

Patients who were eligible for immunisation in the first two years of the programme but have not yet been vaccinated will remain eligible until their 80th birthday. These are:

  • Patients aged 71 and 72 years on 1st September 2015; and 
  • Patients aged 79 years on 1 September 2015

Until 31st August 2015, GPs should continue to offer the shingles vaccine to patients who were aged 70, 78 or 79 years on 1st September 2014.

Any patient who has reached their 80th birthday is no longer eligible for the vaccine. This reflects recommendations made by the Joint Committee on Vaccination and Immunisation, due to the declining efficacy of the vaccine as age increases.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases